Patients were randomly assigned to receive docetaxel alone ( 36 mg/m ( 2 ) , days 1 and 8 ) or docetaxel ( 36 mg/m ( 2 ) , days 1 and 8 ) and oxaliplatin ( 80 mg/m ( 2 ) , day 1 ) combination therapy every three weeks .